Development and Analytical Validation of a Smartphone‐Based Quantitative Lateral Flow Immunoassay for Serum Cystatin‐C
Journal of Clinical Laboratory Analysis · 2026-11 · 40 (21)
DOI: 10.1002/jcla.70372 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 06.10.2026. Verfasst von Ye Lian und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, China. Hauptthemen laut MEDLINE: Smartphone, Cystatin C. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National College Students Innovation and Entrepreneurship Training Program.
Abstract (Originalsprache)
Background
Cystatin‐C is an important renal function biomarker, but conventional quantification requires centralized laboratory analyzers, limiting timely testing in primary care and resource‐limited settings.
Methods
We developed and validated a quantitative smartphone‐based lateral flow immunoassay (SP‐LFIA) comprising a colorimetric strip, a Redmi Note 12R smartphone, a fixed‐geometry macro‐lens module with integrated LED illumination, and an Android application. The application directly converted background‐corrected test/control‐line (T/C) ratios into concentrations using a batch‐specific third‐order polynomial calibration model. Analytical validation followed relevant Clinical and Laboratory Standards Institute guidelines.
Results
The assay showed a quantitative range of 0.32–8.00 mg/L and a limit of detection of 0.15 mg/L. Intra‐ and inter‐assay coefficients of variation were below 10%. No significant interference was observed from bilirubin, triglycerides, hemoglobin, rheumatoid factor, gentamicin sulfate, norvancomycin hydrochloride, or cisplatin at the tested concentrations. Accelerated testing supported strip performance after storage at 50°C for 28 days. In 120 clinical serum samples, SP‐LFIA agreed closely with the commercial particle‐enhanced turbidimetric immunoassay reference method (R 2 = 0.9946), with a mean bias of −0.01 mg/L.
Conclusion
The smartphone‐based LFIA provides a reliable, rapid, low‐cost, and practical approach to quantitative Cystatin‐C testing in point‐of‐care settings where serum preparation is available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, China.
- First School of Medicine (School of Information and Engineering), Wenzhou Medical University, Wenzhou, China.
- College of Information Science and Engineering, Ningbo University, Ningbo, China.
- School of Laboratory Medicine (School of Life Sciences), Wenzhou Medical University, Wenzhou, China.
- Clinical Laboratory Center, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Guojun Lian
Förderung
- National College Students Innovation and Entrepreneurship Training Program
Zitieren
APA
Lian, Y., Zheng, R., Yang, C., Luo, Y., Zhang, N., Lian, G., & Li, B. (2026). Development and Analytical Validation of a Smartphone‐Based Quantitative Lateral Flow Immunoassay for Serum Cystatin‐C. Journal of Clinical Laboratory Analysis, 40(21). https://doi.org/10.1002/jcla.70372
Vancouver
Lian Y, Zheng R, Yang C, Luo Y, Zhang N, Lian G, et al. Development and Analytical Validation of a Smartphone‐Based Quantitative Lateral Flow Immunoassay for Serum Cystatin‐C. Journal of Clinical Laboratory Analysis. 2026;40(21). doi:10.1002/jcla.70372
BibTeX
@article{Lian2026,
author = {Lian, Ye and Zheng, Ruiying and Yang, Chenqi and Luo, Yueyang and Zhang, Na and Lian, Guojun and Li, Baoqing},
title = {Development and Analytical Validation of a Smartphone‐Based Quantitative Lateral Flow Immunoassay for Serum Cystatin‐C},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
volume = {40},
number = {21},
doi = {10.1002/jcla.70372}
}
EUVIMED